How many patents does
Exelixis have?
patents
1,750
families
188
granted
429
applications
1,321
US
306
EP
182
WO
114
JP
100
CN
89
KR
65
RoW
894
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Exelixis
Top ten assignees appearing on patents
2009 - 2018
2009
| exelixis | 107 |
| symphony evolution | 4 |
| x-ceptor therapeutics | 1 |
2018
| exelixis | 69 |
| genentech | 8 |
| symphony evolution | 2 |
| exelixis patent company | 2 |
| bristol-myers squibb company | 2 |
| sanofi | 1 |
Exelixis
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| c-met modulators and methods of use | 82 | 2003 |
| malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl] oxy}phenyl)-n' - (4 -fluor… 🛈 | 63 | 2009 |
| azetidines as mek inhibitors for the treatment of proliferative diseases | 59 | 2005 |
| methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha | 41 | 2007 |
| lxr modulators | 41 | 2009 |
| combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the tre… 🛈 | 40 | 2007 |
| c-met modulator pharmaceutical compositions | 39 | 2010 |
| novel process for making compounds for use in the treatment of cancer | 39 | 2012 |
| pyridopyrimidinone inhibitors of pi3kα for the treatment of cancer | 38 | 2005 |
| phosphatidylinositol 3-kinase inhibitors and methods of their use | 37 | 2005 |